about
Apoptosis: targets in pancreatic cancerEffects of STI571 (gleevec) on pancreatic cancer cell growthIdentification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activityOSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signalingEndonuclein is a cell cycle regulated WD-repeat protein that is up-regulated in adenocarcinoma of the pancreas.Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice.Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancerInhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cellsOverexpression of annexin 1 in pancreatic cancer and its clinical significance.New tumor-associated antigen SC6 in pancreatic cancer.Proteomic analysis of differential proteins in pancreatic carcinomas: Effects of MBD1 knock-down by stable RNA interference.Src as the link between inflammation and cancer.Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors.Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides.Mechanism for Src activation by the CCK2 receptor: Patho-physiological functions of this receptor in pancreas.Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of thDiffering Src signaling levels have distinct outcomes in Drosophila.Growth factor mediated signaling in pancreatic pathogenesisExploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.
P2860
Q24800170-0FEB1DCF-E2AE-4092-B8FE-234A6DF28D04Q24802841-F9083C0E-0C36-436C-9D6D-3CC010AC33A3Q33520350-66B3709B-E8AE-46F3-96EF-1377732BE444Q33710074-A45E8447-2706-41AB-AF94-580C5E481B6DQ34114668-3192E06B-E548-4CE9-AAB1-26DE5592F7C4Q34768930-0F83717A-1AAB-4157-A529-ED652A3FC3B3Q34972461-6A783F62-FCA2-4E2B-885F-373890B4B289Q35088031-3D4E4808-C54F-4303-BD32-D534F856359AQ35522087-6997B167-4384-4D95-B07B-BF74277DBD69Q36308123-495136C5-E0AA-4579-88AD-FC4FC6AC003CQ36503356-C90AE47C-4007-47A0-9E4F-C881E5188E17Q36661553-BA756533-BB00-400F-A0B0-B795B606D8EDQ37486211-85F5F863-1781-4C1C-A386-D0FE5D66E951Q37613072-C7CF6555-37AF-4651-821F-B7821099743FQ39942125-02878EE7-004C-4D2F-85C7-FA5F649495D3Q40250328-9B764FC6-1D5F-4370-81AA-853E6EC6FF68Q40758258-05B483C1-B81C-44B2-8AB5-4F3A7C49D083Q41456604-DFC468FC-9C66-4F73-B5DF-74C1B7B870EAQ41871117-C15F4A16-4C1E-4620-B7E6-DF3F20D712D2Q51825149-B448A303-1E60-4E0A-81A6-12D032736B39
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular prognostic markers in pancreatic cancer.
@ast
Molecular prognostic markers in pancreatic cancer.
@en
Molecular prognostic markers in pancreatic cancer.
@nl
type
label
Molecular prognostic markers in pancreatic cancer.
@ast
Molecular prognostic markers in pancreatic cancer.
@en
Molecular prognostic markers in pancreatic cancer.
@nl
prefLabel
Molecular prognostic markers in pancreatic cancer.
@ast
Molecular prognostic markers in pancreatic cancer.
@en
Molecular prognostic markers in pancreatic cancer.
@nl
P1433
P1476
Molecular prognostic markers in pancreatic cancer.
@en
P2093
P304
P356
10.1177/107327480000700504
P577
2000-09-01T00:00:00Z